InformationInformation Center

03 2018-05
Introduction of Shengming Bio

Introduction of Shengming Bio

Shengming Bio is wholly owned subsidiary of Hualan Group and can provide CRO and CMO services related to monoclonal antibody drugs that fully meet the requirements of CFDA/FDA.

06 2018-02
Situation Update in USA: Summary of Weekly FluView Activity Report

Situation Update in USA: Summary of Weekly FluView Activity Report

According to the latest FluView report, Influenza activity increased again in USA. The overall hospitalization rate is higher than the overall hospitalization rate reported during the same week of the 2014-2015 season; the most severe season in recent years.

10 2017-11
Human Coagulation Factor VIII

Human Coagulation Factor VIII

Hualan Biological produces plasma and vaccines more than 25 years, including Human Albumin, IVIG, Human Coagulation Factor VIII, Vaccines and other biological products.